Hence, to circumvent the embryonic lethality and to study the role of these tumor suppressors in pancreatic development and malignant transformation, we specifically deleted Palb2, Brca1 or Brca2 in the pancreas only using the Cre-LoxP recombination technology. This evidence concerns the gene BRCA2 and neoplasm.